LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the industry.
The company said that Derodra has agreed to take up the role of finance head at diagnostic services company Unilabs.
Vectura said that Derodra will remain in the position until the end of July in order to ensure a smooth transition process. Vectura has already started a search for replacement, it said.
"I would like to thank Andrew both personally and on behalf of the Vectura Board for his continued support and contribution to the success of Vectura," said Chief Executive James Ward-Lilley.
"He leaves the transformed Vectura in good shape and with a strong outlook, well-positioned to capitalise on the great opportunities with our inhaled in-market products and refocussed pipeline portfolio. We wish Andrew every success in his new role," Ward-Lilley added.
Shares in Vectura were down 3.7% at 100.50 pence per share on Friday, the worst performer in the FTSE 250.
